[Mutagenic activity of psychotropic and anticonvulsant drugs].
D000701:Analgesics, Opioid / Q000494:pharmacology; D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology; D000927:Anticonvulsants / Q000494:pharmacology*; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology; D014150:Antipsychotic Agents / Q000494:pharmacology; D001569:Benzodiazepines; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D002869:Chromosome Aberrations; D004330:Drosophila; D005260:Female; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D008094:Lithium / Q000494:pharmacology; D008214:Lymphocytes / Q000648:ultrastructure; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008297:Male; D009153:Mutagens; D010640:Phenothiazines; D011619:Psychotropic Drugs / Q000494:pharmacology*; D012110:Reserpine / Q000494:pharmacology
D000701:Analgesics, Opioid; D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D000697:Central Nervous System Stimulants; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D009153:Mutagens; D010640:Phenothiazines; D011619:Psychotropic Drugs; D001569:Benzodiazepines; D012110:Reserpine; D008238:Lysergic Acid Diethylamide; D008094:Lithium
O mutagennoĭ aktivnosti psikhotropnykh i protivosudorozhnykh preparatov